News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
Kerry Grens | Feb 26, 2018
One dose of the medication, called Xofluza, cripples influenza by interfering with an enzyme critical for viral replication.
Tamiflu Reviewed Again
Kerry Grens | Jan 30, 2015
The controversial antiviral drug earns better marks in the most recent analysis of the evidence.
Researchers Question Tamiflu Review
Tracy Vence | Apr 23, 2014
Critics claim updated analysis of antiviral medication was statistically weak and based on unreliable randomized clinical trial data.
Updated Review: Tamiflu Is a Bust
Kerry Grens | Apr 10, 2014
After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.
Kerry Grens | May 1, 2012
What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.